Therapeutic factor VIII antibodies
US9062115B2 · kind B2 · utility
6Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 15, 2011 |
| Grant date | Jun 23, 2015 |
| Priority date | — |
| Expiry date | Sep 15, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to therapeutic FVIII antibodies. In particular, the present invention relates to FVIII antibodies having the ability to prolong the circulatory half life of FVIII. The present invention furthermore relates to use of such antibodies in treatment and prophylaxis of haemophilia A.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.